Stay updated on Subcutaneous Lirentelimab in Atopic Dermatitis Clinical Trial

Sign up to get notified when there's something new on the Subcutaneous Lirentelimab in Atopic Dermatitis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Subcutaneous Lirentelimab in Atopic Dermatitis Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Revision updated from v3.5.3 to v3.5.4 on the page, signaling a new release of the site rendering. The content and study details remain unchanged aside from metadata.
    Difference
    0.0%
    Check dated 2026-05-18T03:45:02.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    No Change Detected
  5. Check
    35 days ago
    Change Detected
    Summary
    The page footer revision label has been updated from **Revision: v3.5.0** to **Revision: v3.5.3**.
    Difference
    0.0%
    Check dated 2026-04-26T15:37:33.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    The page now shows a revision label, Revision: v3.5.0, replacing the previous Revision: v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-21T20:25:02.000Z thumbnail image
  7. Check
    85 days ago
    Change Detected
    Summary
    The page now displays the latest revision label (v3.4.3) and removes the previous revision (v3.4.2).
    Difference
    0.0%
    Check dated 2026-03-07T13:20:11.000Z thumbnail image
  8. Check
    107 days ago
    Change Detected
    Summary
    The page shows a revision bump from v3.4.1 to v3.4.2 with no changes to study content, eligibility criteria, endpoints, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-13T17:25:19.000Z thumbnail image
  9. Check
    114 days ago
    Change Detected
    Summary
    A minor revision update from v3.4.0 to v3.4.1; core study details remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-06T13:37:56.000Z thumbnail image

Stay in the know with updates to Subcutaneous Lirentelimab in Atopic Dermatitis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Subcutaneous Lirentelimab in Atopic Dermatitis Clinical Trial page.